Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
[Arsenic, leukemia and old horses].
Lakartidningen    July 27, 1999   Volume 96, Issue 25 3057 
Kjellson L.No abstract available
[Nutrition of horses: digestion, energy and protein evaluation and nutritional standards].
Tijdschrift voor diergeneeskunde    July 27, 1999   Volume 124, Issue 13 401-405 
van 't Klooster AT, Hallebeek JM, Beynen AC.The diet of horses should cover the energy and nutrient requirements of these animals. The desired composition of the ration depends on its digestion in the equine gastrointestinal tract. Nutritional problems or diseases caused by incorrect composition of the ration or by incorrect feeding should be prevented. The digestion of carbohydrates, fats, and proteins in the different parts of the gastrointestinal tract is described. In addition, the recently introduced net energy and digestible protein evaluation systems for feeds, and the energy and protein requirements of horses are presented.
Inhibition of articular cartilage degradation in culture by a novel nonpeptidic matrix metalloproteinase inhibitor.
Annals of the New York Academy of Sciences    July 23, 1999   Volume 878 594-597 doi: 10.1111/j.1749-6632.1999.tb07737.x
Billinghurst RC, O'Brien K, Poole AR, McIlwraith CW.No abstract available
Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.
American journal of veterinary research    July 17, 1999   Volume 60, Issue 7 888-894 
Rees WA, Harkins JD, Lu M, Holland RE, Lehner AF, Tobin T, Chambers TM.To determine pharmacokinetics of single and multiple doses of rimantadine hydrochloride in horses and to evaluate prophylactic efficacy of rimantadine in influenza virus-infected horses. Methods: 5 clinically normal horses and 8 horses seronegative to influenza A. Methods: Horses were given rimantadine (7 mg/kg of body weight, i.v., once; 15 mg/kg, p.o., once; 30 mg/kg, p.o., once; and 30 mg/kg, p.o., q 12 h for 4 days) to determine disposition kinetics. Efficacy in induced infections was determined in horses seronegative to influenza virus A2. Rimantadine was administered (30 mg/kg, p.o., q 1...
Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.
Vaccine    July 14, 1999   Volume 17, Issue 18 2245-2258 doi: 10.1016/s0264-410x(98)00496-4
Lunn DP, Soboll G, Schram BR, Quass J, McGregor MW, Drape RJ, Macklin MD, McCabe DE, Swain WF, Olsen CW.Equine influenza virus infection remains one of the most important infectious diseases of the horse, yet current vaccines offer only limited protection. The equine immune response to natural influenza virus infection results in long-term protective immunity, and is characterized by mucosal IgA and serum IgGa and IgGb antibody responses. DNA vaccination offers a radical alternative to conventional vaccines, with the potential to generate the same protective immune responses seen following viral infection. Antigen-specific antibody isotype responses in serum and mucosal secretions were studied i...
New treatment technologies demand rigorous evaluation.
Equine veterinary journal    July 13, 1999   Volume 31, Issue 3 184 doi: 10.1111/j.2042-3306.1999.tb03169.x
Kaneps AJ.No abstract available
Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
Journal of the American Veterinary Medical Association    July 9, 1999   Volume 215, Issue 1 61-66 
Morley PS, Townsend HG, Bogdan JR, Haines DM.To evaluate efficacy of a commercial vaccine for prevention of infectious upper respiratory tract disease (IURD) caused by equine influenza virus. Methods: Double-masked, randomized, controlled field trial. Methods: 462 horses stabled at a Thoroughbred racetrack. Methods: Vaccine or saline solution placebo was administered 4 times in the population at 6-week intervals. The vaccine contained 3 strains of inactivated influenza virus, and inactivated equine herpesvirus type 4. Horses received 1 or 2 doses of vaccine or placebo prior to onset of a natural influenza epidemic, and were examined 5 d/...
[Botulism–a forgotten disease?].
Berliner und Munchener tierarztliche Wochenschrift    May 25, 1999   Volume 112, Issue 4 139-145 
Böhnel H.The laboratory diagnosis of C. botulinum is described for cattle and horses in the years 1995-1998. Out of 122 cases 66 were positive. All types of toxins were identified; in cattle mainly types C and D. In 9 cases typing was not conclusive. The results of an enquiry of afflicated animal owners showed, that modern agricultural technology has an important impact on toxinogenesis in feed stuff. Possibilities to prevent the disease and to reduce economic losses are discussed; a solution cannot be presented.
Prediction of long-term outcome following grass sickness (equine dysautonomia).
The Veterinary record    May 18, 1999   Volume 144, Issue 14 386-387 doi: 10.1136/vr.144.14.386
Doxey DL, Milne EM, Gwilliam R, Sandland J.No abstract available
Strategic control of gastrointestinal nematode and lungworm infections with eprinomectin at turnout and eight weeks later.
The Veterinary record    May 18, 1999   Volume 144, Issue 14 380-382 doi: 10.1136/vr.144.14.380
Epe C, Woidtke S, Pape M, Heise M, Kraemer F, Kohlmetz C, Schnieder T.Two groups of 10 first-year grazing cattle were either left untreated as controls (group 1) or treated with eprinomectin as a pour-on application at turnout and eight weeks later (group 2). The control group developed a mild infection with gastrointestinal nematodes and lungworms during the season, whereas the treated animals remained healthy. The interval between the treatments allowed the establishment of adult worms, but the egg counts remained negligible. The total number of eggs shed by the treated cattle during the grazing season was significantly smaller than by the controls.
Tapeworms as a cause of intestinal disease in horses.
Parasitology today (Personal ed.)    May 14, 1999   Volume 15, Issue 4 156-159 doi: 10.1016/s0169-4758(99)01416-7
Proudman CJ, Trees AJ.Until recently, the equine tapeworm Anoplocephala perfoliata was difficult to diagnose and considered to be of questionable pathogenicity. Here, Chris Proudman and Sandy Trees describe recent advances in the immunodiagnosis of this parasite that have facilitated epidemiological studies. These studies suggest that A. perfoliata may be an important cause of intestinal disease in the horse and demonstrate a dose-response relationship between infection intensity and risk of disease. If tapeworm infection is a risk factor for ileocaecal colic, the identification and treatment of infected individual...
Pulmonary aspergillosis in horses: 29 cases (1974-1997).
Journal of the American Veterinary Medical Association    April 2, 1999   Volume 214, Issue 6 808-811 
Sweeney CR, Habecker PL.To analyze medical records and identify factors that veterinarians can use to prevent pulmonary aspergillosis in horses or that would enable them to diagnose it as early as possible. Methods: Retrospective study. Methods: 29 horses. Methods: Medical records were reviewed for horses with pulmonary aspergillosis diagnosed on the basis of characteristic postmortem findings. Information on history, clinical signs, disease progression, and postmortem findings was obtained. Results: 25 of 29 (86.2%) horses had primary (n = 20) or secondary (5) disease compatible with loss of integrity of the gastroi...
Control of equine viral arteritis.
The Veterinary record    March 31, 1999   Volume 144, Issue 7 186 
Parker J.No abstract available
A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
Virology    February 3, 1999   Volume 254, Issue 1 37-49 doi: 10.1006/viro.1998.9550
Hammond SA, Cook SJ, Falo LD, Issel CJ, Montelaro RC.Immunization regimens that induce a broadly reactive cytolytic T lymphocyte (CTL) response specific for lentiviral antigens have emerged as the leading candidates in efficacy trials conducted in both animal modelshumans. To date, lentivirus vaccination strategies have overlooked one such immunization strategy, namely the use of particulate antigens. To evaluate the efficacy of targeting antigen into the phagocytic pathway to elicit a cell-mediated immune response to lentiviral antigens, we initiated the first study of a particulate-based vaccination protocol using a large animal model system. ...
The equine influenza surveillance program.
Advances in veterinary medicine    January 16, 1999   Volume 41 379-387 doi: 10.1016/s0065-3519(99)80028-7
Mumford JA.No abstract available
Vaccination against Strongylus vulgaris in ponies: comparison of the humoral and cytokine responses of vaccinates and nonvaccinates.
Advances in veterinary medicine    January 16, 1999   Volume 41 389-404 doi: 10.1016/s0065-3519(99)80029-9
Swiderski CE, Klei TR, Folsom RW, Pourciau SS, Chapman A, Chapman MR, Moore RM, McClure JR, Taylor HW, Horohov DW.No abstract available
Diagnosis and prevention of equine infectious diseases: present status, potential, and challenges for the future.
Advances in veterinary medicine    January 16, 1999   Volume 41 359-377 doi: 10.1016/s0065-3519(99)80027-5
Desmettre P.The frequent transfers of horses, whether on a permanent or temporary basis, make strict control of infectious diseases essential. Such control needs a reliable and rapid means to accurately diagnose the relevant diseases. Indirect diagnosis based on antibody detection remains certainly the best method to secure the epidemiologic surveillance of the diseases at regional, national, or even world level, while direct diagnosis is the only way to diagnose a new outbreak. New diagnostic methods resulting from advances in biochemistry, molecular biology, and immunology are now available. As far as a...
Availability of equine medicines.
The Veterinary record    January 9, 1999   Volume 143, Issue 23 643 
Mantell JA.No abstract available
Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
Bulletin of the World Health Organization    December 30, 1998   Volume 76, Issue 5 491-495 
Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C.WHO's reference protocol for post-exposure rabies vaccination advises five intramuscular injections on days 0, 3, 7, 14, and 30; in addition, rabies immunoglobulins (RIG) must be given to serious cases of exposure (grade III severity). Some studies indicate that these immunoglobulins suppress the immunogenicity of rabies vaccine when administered according to an alternative protocol of four injections (2-1-1) on days 0, 7, and 21, which was therefore not recommended for grade III exposures. To test this effect, we conducted a multicentre study in Indonesia using three groups of subjects. One g...
[New drugs for horses and agriculturally useful animals and changes in the pharmaceutical market since 1996].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 19, 1998   Volume 26, Issue 6 301-306 
Kluge K, Ungemach FR.No abstract available
Nosocomial infections: listening to human experience may help the horse.
Equine veterinary journal    December 9, 1998   Volume 30, Issue 6 450-451 doi: 10.1111/j.2042-3306.1998.tb04517.x
Sage R.No abstract available
The Dorothy Russell Havemeyer Foundation Third International Workshop on Equine Perinatology: comparative aspects. Proceedings.
Equine veterinary journal    December 9, 1998   Volume 30, Issue 6 455-466 doi: 10.1111/j.2042-3306.1998.tb04520.x
No abstract available
Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus.
Journal of the American Veterinary Medical Association    December 5, 1998   Volume 213, Issue 11 1586-1570 
Balasuriya UB, Evermann JF, Hedges JF, McKeirnan AJ, Mitten JQ, Beyer JC, McCollum WH, Timoney PJ, MacLachlan NJ.A virus isolated from an aborted equine fetus was determined to be antigenically distinct from several other strains of equine arteritis virus (EAV) by use of a neutralization assay with a large panel of neutralizing monoclonal antibodies. The virus was readily neutralized by polyclonal equine anti-EAV serum. Comparative nucleotide and amino acid sequence analyses indicated that the virus (WA97) isolated from the aborted fetus was virtually identical to a virus (S1971) isolated from imported semen used to inseminate another mare on the farm. Phylogenetic analysis indicated that the WA97/S1971 ...
[Meconium obstipation in the foal].
Tijdschrift voor diergeneeskunde    December 4, 1998   Volume 123, Issue 22 671-672 
Boerma S.No abstract available
Epidemiology of equine herpesvirus abortion: searching for clues to the future.
Australian veterinary journal    November 27, 1998   Volume 76, Issue 10 675-676 doi: 10.1111/j.1751-0813.1998.tb12280.x
Gilkerson JR, Love DN, Whalley JM.No abstract available
Concerns about medicines availability highlighted at BEVA congress.
The Veterinary record    November 4, 1998   Volume 143, Issue 13 346-347 
No abstract available
Persistence of the efficacy of a moxidectin gel on the establishment of cyathostominae in horses.
The Veterinary record    October 28, 1998   Volume 143, Issue 11 307-309 doi: 10.1136/vr.143.11.307
Vercruysse J, Eysker M, Demeulenaere D, Smets K, Dorny P.A controlled trial was carried out to evaluate the persistence of the effect against small strongyles of a 2 per cent moxidectin gel administered orally to foals at a dose rate of 0.4 mg/kg bodyweight. Five of nine helminth-free foals were treated on day 0, and the remaining four foals were used as controls. On days 0, 7, 14, 21 and 28 all nine foals were infected experimentally with 200,000 small strongyle larvae. Three treated and two control foals were necropsied on day 42 and the rest on day 43. Fourteen species of small or medium sized small strongyles were found in the control foals, 10 ...
Future international management of African horse sickness vaccines.
Archives of virology. Supplementum    October 24, 1998   Volume 14 297-304 doi: 10.1007/978-3-7091-6823-3_25
House JA.Three types of African horse sickness (AHS) vaccine, namely adult mouse brain, modified live vaccine and inactivated viral vaccine (IVV) are reviewed. The results of efficacy trials carried out with each vaccine type highlight the advantages of the IVV. Vaccination with African horse sickness virus serotype 4 IVV, given as 2 separate doses, provided full protection against subsequent, homologous challenge. The absence of any detectable viraemia after challenge would also prevent infection of insect vectors. The advantages of establishing international vaccine banks for AHS are discussed.
Simulation studies of African horse sickness in Spain.
Archives of virology. Supplementum    October 24, 1998   Volume 14 103-111 doi: 10.1007/978-3-7091-6823-3_11
Lord CC, Woolhouse ME, Mellor PS.Factors affecting epidemics of African horse sickness in Spain were studied using a mathematical model. The model examined the likelihood of an epidemic after the introduction of the virus, and the effectiveness of vaccination strategies. Two host species (horses and donkeys) and one vector species (the biting midge Culicoides imicola) were included. A stratified random sampling method (Latin hypercube sampling) was used for sensitivity analysis of the likelihood of an epidemic. Systematic variation of vaccination parameters was used to consider alternative control strategies. In general, when...
Farm and animal exposures and pediatric brain tumors: results from the United States West Coast Childhood Brain Tumor Study. Holly EA, Bracci PM, Mueller BA, Preston-Martin S.Nineteen counties from San Francisco and Los Angeles, California and Seattle, Washington were the United States sites for a large population-based case-control study of childhood brain tumors (CBTs), sponsored by the National Cancer Institute. CBT patients who were 1 year and were first on a farm when they were < 6 months of age also had increased risk for CBTs (OR = 3.9, 95% CI = 1.2-13). A somewhat increased risk for CBTs was found for children of mothers who ever had worked on livestock farms compared with mothers who never had worked on a farm (OR = 7.4, 95% CI = 0.86-64, based on five...
1 74 75 76 77 78 119